Efficacy and Safety Study of Augmentation Therapy With ARALAST Fraction IV-1 (Human Alpha 1 - Proteinase Inhibitor)

NCT00396006 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Alpha 1-Antitrypsin Deficiency

Interventions

BIOLOGICAL: Alpha1-Proteinase Inhibitor

Sponsor

Baxalta now part of Shire